Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
This overview has been developed for program planners considering introduction and/or expansion of the use of oxytocin, and in particular oxytocin packaged in the Uniject™ device, to reduce the incidence of postpartum hemorrhage as a component of their maternal and child health programming. Administering oxytocin is just one component of active management of third stage labor.
Publication date: September 2008
Available materials
-
English
-
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
- PDF
Hard copies are not available.
-
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
- PDF
-
Spanish
-
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
- PDF
Hard copies are not available.
-
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
- PDF